Top

Published in:

Open Access 01-07-2017 | Substantive Review

A Systematic Review and Meta-analysis of Psychosocial Interventions to Reduce Drug and Sexual Blood Borne Virus Risk Behaviours Among People Who Inject Drugs

Authors: Gail Gilchrist, Davina Swan, Kideshini Widyaratna, Julia Elena Marquez-Arrico, Elizabeth Hughes, Noreen Dadirai Mdege, Marrissa Martyn-St James, Judit Tirado-Munoz

Published in: AIDS and Behavior | Issue 7/2017

Abstract

Opiate substitution treatment and needle exchanges have reduced blood borne virus (BBV) transmission among people who inject drugs (PWID). Psychosocial interventions could further prevent BBV. A systematic review and meta-analysis examined whether psychosocial interventions (e.g. CBT, skills training) compared to control interventions reduced BBV risk behaviours among PWID. 32 and 24 randomized control trials (2000-May 2015 in MEDLINE, PsycINFO, CINAHL, Cochrane Collaboration and Clinical trials, with an update in MEDLINE to December 2016) were included in the review and meta-analysis respectively. Psychosocial interventions appear to reduce: sharing of needles/syringes compared to education/information (SMD −0.52; 95% CI −1.02 to −0.03; I² = 10%; p = 0.04) or HIV testing/counselling (SMD −0.24; 95% CI −0.44 to −0.03; I² = 0%; p = 0.02); sharing of other injecting paraphernalia (SMD −0.24; 95% CI −0.42 to −0.06; I² = 0%; p < 0.01) and unprotected sex (SMD −0.44; 95% CI −0.86 to −0.01; I² = 79%; p = 0.04) compared to interventions of a lesser time/intensity, however, moderate to high heterogeneity was reported. Such interventions could be included with other harm reduction approaches to prevent BBV transmission among PWID.

Available only for authorised users

Hahné SJ, Veldhuijzen IK, Wiessing L, Lim TA, Salminem M, Laar MV. Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening. BMC Infect Dis. 2013;13:181.CrossRefPubMedPubMedCentral

Mathers BM, Degenhardt L, Phillips B, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008;372(9651):1733–45.CrossRefPubMed

Baeten J, Celum C. Systemic and topical drugs for the prevention of HIV infection: antiretroviral pre-exposure prophylaxis. Annu Rev Med. 2013;64:219–32.CrossRefPubMed

Aspinall EJ, Corson S, Doyle JS, et al. Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis. Clin Infect Dis. 2013;57(Suppl 2):S80–9.CrossRefPubMed

MacArthur GJ, van Velez E, Palmateer N, et al. Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness. Int J Drug Policy. 2014;25(1):34–52.CrossRefPubMed

Hagan H, Pouget ER, Des Jarlais DC. A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs. J Infect Dis. 2011;204(1):74–83.CrossRefPubMedPubMedCentral

Meader N, Li R, Des Jarlais DC, Pilling S. Psychosocial interventions for reducing injection and sexual risk behaviour for preventing HIV in drug users. Cochrane Database Syst Rev. 2010;1:CD007192.

Meader N, Semaan S, Halton M, et al. An international systematic review and meta-analysis of multisession psychosocial interventions compared with educational or minimal interventions on the HIV sex risk behaviors of people who use drugs. AIDS Behav. 2013;17(6):1963–78.CrossRefPubMed

Sacks-Davis R, Horyniak D, Grebely J, Hellard M. Behavioural interventions for preventing hepatitis C infection in people who inject drugs: a global systematic review. Int J Drug Policy. 2012;23(3):176–84.CrossRefPubMed

10.

Michie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6:42.CrossRefPubMedPubMedCentral

11.

Harrell PT, Mancha BE, Petras H, Trenz RC, Latimer WW. Latent classes of heroin and cocaine users predict unique HIV/HCV risk factors. Drug Alcohol Depend. 2012;122(3):220–7.CrossRefPubMed

12.

Booth RE, Strathdee SA. Baseline findings from the third collaborative injection drug users study/drug users intervention trial (CIDUS III/DUIT). Drug Alcohol Depend. 2007;91(Suppl 1):S1–3.CrossRefPubMed

13.

Gilchrist G, Singleton N, Donmall M, Jones A. Prevalence and factors associated with sex trading in the year prior to entering treatment for drug misuse in England. Drug Alcohol Depend. 2015;152:116–22.CrossRefPubMed

14.

Jin H, Huriaux E, Loughran E, Packer T, Raymond HF. Differences in HIV risk behaviors among people who inject drugs by gender and sexual orientation, San Francisco, 2012. Drug Alcohol Depend. 2014;145:180–4.CrossRefPubMed

15.

Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006–12.CrossRefPubMed

16.

Higgins JP, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.CrossRefPubMedPubMedCentral

17.

Booth RE, Campbell BK, Mikulich-Gibertson SK, et al. Reducing HIV-related risk behaviors among injection drug users in residential detoxification. AIDS Behav. 2011;15(1):30–44.CrossRefPubMedPubMedCentral

18.

Latkin CA, Donell D, Metzger D, et al. The efficacy of a network intervention to reduce HIV risk behaviors among drug users and risk partners in Chiang Mai, Thailand and Philadelphia, USA. Soc Sci Med. 2009;68(4):740–8.CrossRefPubMed

19.

Zule WA, Costenbader EC, Curtis CM, Wechsberg WM. Effects of a hepatitis C virus educational intervention or a motivational intervention on alcohol use, injection drug dse, and sexual risk behaviours among injection drug users. Am J Public Health. 2009;99(Suppl 1):S180–6.CrossRefPubMedPubMedCentral

20.

Schroeder JR, Epstein DH, Umbricht A, Preston KL. Changes in HIV risk behaviors among patients receiving combined pharmacological and behavioral interventions for heroin and cocaine dependence. Addict Behav. 2006;31(5):868–79.CrossRefPubMed

21.

Latkin CA, Sherman S, Knowlton A. HIV prevention among drug users: outcome of a network-oriented peer outreach intervention. Health Psychol. 2003;22(4):332–9.CrossRefPubMed

22.

Gilbert L, El-Bassel N, Terlikbayeva A, et al. Couple-based HIV prevention for injecting drug users in Kazakhstan: a pilot intervention study. J Prev Interv Community. 2010;38(2):162–76.CrossRefPubMed

23.

Hoffman IF, Latkin CA, Kukhareva PV, et al. A peer-educator network HIV prevention intervention among injection drug users: results of a randomized controlled trial in St. Petersburg, Russia. AIDS Behav. 2013;17(7):2510–20.CrossRefPubMedPubMedCentral

24.

Wechsberg WM, Krupitsky E, Romanova T, et al. Double jeopardy-drug and sex risks among Russian women who inject drugs: initial feasibility and efficacy results of a small randomized controlled trial. Subst Abuse Treat Prev Policy. 2012;7:1.CrossRefPubMedPubMedCentral

25.

Tobin KE, Kuramoto SJ, Davey-Rothwell MA, Latkin CA. The STEP into Action study: a peer-based, personal risk network-focused HIV prevention intervention with injection drug users in Baltimore, Maryland. Addiction. 2011;106(2):366–75.CrossRefPubMed

26.

Strathdee SA, Abramovitz D, Lozada R, et al. Reductions in HIV/STI incidence and sharing of injection equipment among female sex workers who inject drugs: results from a randomized controlled trial. PLoS ONE. 2013;8(6):e65812.CrossRefPubMedPubMedCentral

27.

Bland JM, Altman DG. Statistics notes. The odds ratio. BMJ. 2000;320:1468.CrossRefPubMedPubMedCentral

28.

Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60.CrossRefPubMedPubMedCentral

29.

Sterk CE, Theall KP, Elifson KW, Kidder D. HIV risk reduction among African-American women who inject drugs: a randomized controlled trial. AIDS Behav. 2003;7(1):73–86.CrossRefPubMed

30.

Go VF, Frangakis C, Minh NL, et al. Efficacy of a multi-level intervention to reduce injecting and sexual risk behaviors among HIV-infected people who inject drugs in Vietnam: a four-arm randomized controlled trial. PLoS ONE. 2015;10(5):e0125909.CrossRefPubMedPubMedCentral

31.

Abou-Saleh M, Davis P, Rice P, et al. The effectiveness of behavioural interventions in the primary prevention of hepatitis C amongst injecting drug users: a randomised controlled trial and lessons learned. Harm Reduct J. 2008;5:25.CrossRefPubMedPubMedCentral

32.

Avants SK, Margolin A, Usubiaga MH, Doebrick C. Targeting HIV-related outcomes with intravenous drug users maintained on methadone: a randomized clinical trial of a harm reduction group therapy. J Subst Abuse Treat. 2004;26(2):67–78.CrossRefPubMed

33.

Bertrand K, Roy É, Vaillancourt É, Vandermeerschen J, Berbiche D, Boivin JF. Randomized controlled trial of motivational interviewing for reducing injection risk behaviours among people who inject drugs. Addiction. 2015;110(5):832–41.CrossRefPubMed

34.

Dushay RA, Singer M, Weeks MR, Rohena L, Gruber R. Lowering HIV risk among ethnic minority drug users: comparing culturally targeted intervention to a standard intervention. Am J Drug Alcohol Abuse. 2001;27(3):501–24.CrossRefPubMed

35.

El-Bassel N, Gilber L, Wu E, et al. Couple-based HIV Prevention for low-income drug users from New York City: a randomized controlled trial to reduce dual risks. J Acquir Immune Defic Syndr. 2011;58(2):198–206.CrossRefPubMed

36.

Epstein DH, Hawkins WE, Covi L, Umbricht A, Preston KL. Cognitive-behavioral therapy plus contingency management for cocaine use: findings during treatment and across 12-month follow-up. Psychol Addict Behav. 2003;17(1):73–82.CrossRefPubMedPubMedCentral

37.

Gagnon H, Godin G, Alary M, Bruneau J, Otis J. A randomized trial to evaluate the efficacy of a computer-tailored intervention to promote safer injection practices among drug users. AIDS Behav. 2010;14(3):538–48.CrossRefPubMed

38.

Garfein RS, Golub ET, Greenberg AE, et al. A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users. AIDS. 2007;21(14):1923–32.CrossRefPubMed

39.

Go VF, Frangakis C, Le Minh N, et al. Effects of an HIV peer prevention intervention on sexual and injecting risk behaviors among injecting drug users and their risk partners in Thai Nguyen, Vietnam: a randomized controlled trial. Soc Sci Med. 2013;96:154–64.CrossRefPubMedPubMedCentral

40.

Hershberger SL, Wood MM, Fisher DG. A cognitive-behavioral intervention to reduce HIV risk behaviors in crack and injection drug users. AIDS Behav. 2003;7(3):229–43.CrossRefPubMed

41.

Latka MH, Hagan H, Kapadia F, et al. A randomized intervention trial to reduce the lending of used injection equipment among injection drug users infected with hepatitis C. Am J Public Health. 2008;98(5):853–61.CrossRefPubMedPubMedCentral

42.

Mackesy-Amiti ME, Oullet LJ, Golub ET, Hudson S, Hagan H, Garfein RS. Predictors and correlates of reduced frequency or cessation of injection drug use during a randomized HIV prevention intervention trial. Addiction. 2011;106(3):601–8.CrossRefPubMed

43.

Margolin A, Avants SK, Warburton LA, Hawkins KA, Shi J. A randomized clinical trial of a manual-guided risk reduction intervention for HIV-positive injection drug users. Health Psychol. 2003;22(2):223–8.CrossRefPubMed

44.

McMahon JM, Pouget ER, Tortu S, Volpe EM, Torres L, Rodriguez W. Couple-based HIV counseling and testing: a risk reduction intervention for US drug-involved women and their primary male partners. Prev Sci. 2015;16(2):341–51.CrossRefPubMedPubMedCentral

45.

McMahon JM, Tortu S, Pouget ER, Torres L, Rodriguz W, Hamid R. Effectiveness of couple-based HIV counseling and testing for women substance users and their primary male partners: a randomized trial. Adv Prev Med. 2013;2013:286207.CrossRefPubMedPubMedCentral

46.

Otiashvili D, Kirtadze I. O´Grady KE, Jones HE. Drug use and HIV risk outcomes in opioid-injecting men in the Republic of Georgia: behavioral treatment + naltrexone compared to usual care. Drug Alcohol Depend. 2012;120(1–3):14–21.CrossRefPubMed

47.

Purcell DW, Latka MH, Metsch LR, et al. Results from a randomized controlled trial of a peer-mentoring intervention to reduce HIV transmission and increase access to care and adherence to HIV medications among HIV-seropositive injection drug users. J Acquir Immune Defic Syndr. 2007;46(Suppl 2):S35–47.CrossRefPubMed

48.

Robles RR, Reyes JC, Colón HM, et al. Effects of combined counseling and case management to reduce HIV risk behaviors among Hispanic drug injectors in Puerto Rico: a randomized controlled study. J Subst Abuse Treat. 2004;27(2):145–52.CrossRefPubMed

49.

Rotheram-Borus MJ, Rhodes F, Desmond K, Weiss RE. Reducing HIV risks among active injection drug and crack users: the safety counts program. AIDS Behav. 2010;14(3):658–68.CrossRefPubMed

50.

Samet JH, Raj A, Cheng DM, et al. HERMITAGE—a randomized controlled trial to reduce sexually transmitted infections and HIV risk behaviors among HIV-infected Russian drinkers. Addiction. 2015;110(1):80–90.CrossRefPubMed

51.

Stein MD, Anderson B, Charuvastra A, Maksad J, Friedmann PD. A brief intervention for hazardous drinkers in a needle exchange program. J Subst Abuse Treat. 2002;22(1):23–31.CrossRefPubMed

52.

Stein MD, Anderson BJ, Solomon DA, et al. Reductions in HIV risk behaviors among depressed drug injectors. Am J Drug Alcohol Abuse. 2005;31(3):417–32.CrossRefPubMed

53.

Stein MD, Herman DS, Anderson BJ. A trial to reduce hepatitis C seroincidence in drug users. J Addict Dis. 2009;28(4):389–98.CrossRefPubMedPubMedCentral

54.

Tucker T, Fry CL, Lintzeris N, et al. Randomized controlled trial of a brief behavioural intervention for reducing hepatitis C virus risk practices among injecting drug users. Addiction. 2004;99(9):1157–66.CrossRefPubMed

55.

Vera A, Abramovitz D, Lozada R, et al. Mujer Mas Segura (Safer Women): a combination prevention intervention to reduce sexual and injection risks among female sex workers who inject drugs. BMC Public Health. 2012;12:653.CrossRefPubMedPubMedCentral

56.

Purcell DW, Metsch LR, Latka M, et al. Interventions for seropositive injectors—research and evaluation: an integrated behavioral intervention with HIV-positive injection drug users to address medical care, adherence, and risk reduction. J Acquir Immune Defic Syndr. 2004;37(Suppl 2):S110–8.CrossRefPubMed

57.

Latkin C, Donnell D, Liu T-Y, Davey-Rothwell M, Celentano D, Metzger D. The dynamic relationship between social norms and behaviors: the results of an HIV prevention network intervention for injection drug users. Addiction. 2013;108(5):934–43.CrossRefPubMedPubMedCentral

58.

Kapadia F, Latka MH, Hagan H, et al. Design and feasibility of a randomized behavioral intervention to reduce distributive injection risk and improve health-care access among hepatitis C virus positive injection drug users: the Study to Reduce Intravenous Exposures (STRIVE). J Urban Health. 2007;81:99–115.CrossRef

59.

60.

Mackesy-Amiti ME, Finnegan L, Ouellet LJ, et al. Peer-education intervention to reduce injection risk behaviors benefits high-risk young injection drug users: a latent transition analysis of the CIDUS 3/DUIT study. AIDS Behav. 2013;17:2075–83.CrossRefPubMed

61.

Mackesy-Amiti ME, Ouellet LJ, Finnegan L, et al. Transitions in latent classes of sexual risk behavior among young injection drug users following HIV prevention intervention. AIDS Behav. 2014;18:464–72.CrossRefPubMed

Title: A Systematic Review and Meta-analysis of Psychosocial Interventions to Reduce Drug and Sexual Blood Borne Virus Risk Behaviours Among People Who Inject Drugs
Authors: Gail Gilchrist
Davina Swan
Kideshini Widyaratna
Julia Elena Marquez-Arrico
Elizabeth Hughes
Noreen Dadirai Mdege
Marrissa Martyn-St James
Judit Tirado-Munoz
Publication date: 01-07-2017
Publisher: Springer US
Published in: AIDS and Behavior / Issue 7/2017
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-017-1755-0

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

A Systematic Review and Meta-analysis of Psychosocial Interventions to Reduce Drug and Sexual Blood Borne Virus Risk Behaviours Among People Who Inject Drugs

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 7/2017

First Report of Gender Based Violence as a Deterrent to Methadone Access Among Females Who Use Heroin in Dar es Salaam, Tanzania

Social Desirability Bias and Prevalence of Sexual HIV Risk Behaviors Among People Who Use Drugs in Baltimore, Maryland: Implications for Identifying Individuals Prone to Underreporting Sexual Risk Behaviors

Event-Level Associations Among Drinking Motives, Alcohol Consumption, and Condomless Anal Sex in a Sample of Young Men Who Have Sex With Men

Concordance Between Laboratory Diagnosed Sexually Transmitted Infections and Self-Reported Measures of Risky Sex by Partner Type Among Rural Ugandan Outpatients

Combining Text Messaging and Telephone Counseling to Increase Varenicline Adherence and Smoking Abstinence Among Cigarette Smokers Living with HIV: A Randomized Controlled Study

Two-Year Trajectories of Sexual Risk Behaviors Among Drug-Using Adolescents and Emerging Adults in an Urban Community

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page